Medical Action Industries Inc. (NASDAQ:MDCI), announced today that it
will hold a conference call to present financial results for the quarter
ended June 30, 2009 on Thursday, August 6, 2009 at 10:00 a.m. (ET).
Paul D. Meringolo, Medical Action’s President and CEO further advised
that our results of operations for the quarter ended June 30, 2009 are
scheduled to be released on Thursday, August 6, 2009 before the market
opens. A conference call will be conducted by Mr. Meringolo, Mr. Charles
L. Kelly, Chief Financial Officer and Mr. Richard G. Satin, Vice
President - General Counsel, to discuss Medical Action’s financial
results.
The conference call will be simultaneously webcast on our website: www.medical-action.com.
The dial-in number for the conference call is (888) 868-9080 (domestic)
or (973) 935-8511 (international); conference ID #20508783.
The complete call and discussion will be available for replay on our
website beginning at 1:00 p.m. (ET) on August 6, 2009.
Medical Action is a diversified manufacturer and distributor of
disposable medical devices and a leader in many of the markets where it
competes. Its products are marketed primarily to acute care facilities
in domestic and certain international markets. The Company has expanded
its target market to include physician, dental and veterinary office,
out-patient surgery centers, long-term care facilities and laboratories.
Medical Action’s products are marketed nationally by its direct sales
personnel and extensive network of healthcare distributors. The Company
has preferred vendor agreements with national and regional distributors,
as well as sole and multi-source agreements with group purchasing
organizations. Medical Action’s common stock trades on the NASDAQ Global
Select Market under the symbol MDCI and is included in the Russell 2000
Index.
This news release contains forward-looking statements that involve
risks and uncertainties regarding Medical Action’s operations and future
results. Please see the Company’s filings with the Securities and
Exchange Commission, including, without limitation, the Company’s Form
10-K and Form 10-Qs, which identify specific factors that would cause
actual results or events to differ materially from those described in
the forward-looking statements.
Medical Action Industries Inc.
Charles L. Kelly, 631-231-4600
Chief
Financial Officer
